Cargando…

OR01-2 Patient Characteristics Associated with Receipt of Prescription Weight Management Medications among Veterans in a Weight Management Program

Objective: Overweight and obesity affect over 4 million veterans receiving health care in the Veterans Administration (VA). In VA, WMM are available to any Veteran who is engaged in behavioral weight management and meets BMI criteria. In 2010, weight management medications (WMM) were found to be und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Dylan, Waring, Molly, Ameli, Omid, Reisman, Joel, Vimalananda, Varsha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554843/ http://dx.doi.org/10.1210/js.2019-OR01-2

Ejemplares similares

SAT-102 Self-efficacy As A Predictor Of Weight Loss In Veterans With Obesity Participating In Medical Weight Management.
por: Parziale, Andrew, et al.
Publicado: (2019)

The Effectiveness of Adding Pharmacotherapy to Dietary Counseling for Veterans in a Veterans Health Administration Move! Weight Management Program
por: Alvarez, Diego Alcaraz, et al.
Publicado: (2021)

OR33-01 Liraglutide for Weight Management in Pubertal Adolescents with Obesity: A Randomized Controlled Trial
por: Kelly, Aaron S, et al.
Publicado: (2020)

Anti-Obesity Medication Prescriptions by Race/Ethnicity and Use of an Interpreter in a Pediatric Weight Management Clinic
por: Bomberg, Eric M, et al.
Publicado: (2021)

SAT-093 Effect of HIV Infection and Antiretroviral Therapy Use on Body Weight and Body Weight Changes over a 5-Year Period in US Veterans
por: Garcia, Jose, et al.
Publicado: (2019)

ODP006 Multidisciplinary Weight Management Improves Body Weight And Body Mass Composition In Breast Cancer Women Undergoing Adjuvant Chemotherapy
por: Nguyen, Vivien, et al.
Publicado: (2022)

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
por: Colleluori, Georgia, et al.
Publicado: (2019)

FRI060 Real World Experience Of Weight Management In Low Socioeconomic Community Clinic
por: West, Brittany Ann, et al.
Publicado: (2023)

Safety and Tolerability of Concomitant Administration of Multiple-Dose AM833 With Semaglutide 2.4 MG for Weight Management
por: Enebo, Lone B, et al.
Publicado: (2021)

SAT-LB019 Improvement of Visceral Fat and Body Composition Endpoints in Participants on Prescription Thyroid Replacement with a Doctor-Supervised Weight Loss Program
por: Dembrowski, Gerald, et al.
Publicado: (2019)

OR01-5 Leptin Acts through Altering Energy Intake and Lipolysis to Reduce Body Weight but Has No Effect on Energy Expenditure, Physical Activity, and Sympathetic Nervous System in Humans
por: Chrysafi, Pavlina, et al.
Publicado: (2019)

PSUN113 Evaluating The Efficacy Of Anti-Obesity Medications In a Multidisciplinary Weight Management Clinic At a VA Medical Center
por: Goettemoeller, Travis, et al.
Publicado: (2022)

OR33-06 Potential Role of Mutations in TBX3 in Human Weight Regulation
por: Xu, Yanjun, et al.
Publicado: (2020)

FRI074 Rise In Fasting Ghrelin Level In Response To Weight Loss Predicts Future Weight Regain In The POUNDS LOST Trial
por: Tong, Jenny, et al.
Publicado: (2023)

Baseline Metabolomic Profile as Potential Biomarker for Weight Change After Roux-en-Y Gastric Bypass Surgery
por: Thaker, Vidhu V, et al.
Publicado: (2021)

Clinically-Relevant Weight Loss is Achieved Independently of Early Weight Loss Response to Once-Weekly Subcutaneous Semaglutide 2.4 MG (STEP 4)
por: Mosenzon, Ofri, et al.
Publicado: (2021)

SAT-113 Cortisol and Weight Regain after Bariatric Surgery
por: Dias, Jenny, et al.
Publicado: (2019)

MON-LB107 Treat: A Randomized Controlled Trial Examining the Effects of Time Restricted Eating on Weight Loss and Metabolic Markers
por: Lowe, Dylan A, et al.
Publicado: (2020)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

SAT-095 The Impact of CPAP on Intensive Calorie Restriction Weight Loss
por: Mao, Yuanjie, et al.
Publicado: (2019)

Weight Loss Mobile Apps: Do They Address COVID-19 and Diabetes
por: Wu, Gloria, et al.
Publicado: (2021)

MON-LB100 Novel Paradoxical Markers of Weight Loss: Is the Worse Actually the Better? a Retrospectiveanalysisof 1,567 Patientswith Obesity With Successful Clinical Weight-Loss Approaches
por: Cadegiani, Flavio, et al.
Publicado: (2020)

FRI075 Single Center Retrospective Matched Cohort Study Of glp1ra-induced Weight Loss In Patients With Post-bariatric Weight Regain Vs Non-surgical Controls
por: Carmen Rivadeneira, Ana Del, et al.
Publicado: (2023)

Longitudinal Weight Gain and Lifestyle Factors in Women With and Without Polycystic Ovary Syndrome
por: Awoke, Mamaru Ayenew, et al.
Publicado: (2021)

Misperception of Weight Is Greater in Healthy Asian Indian Urban Men Than Women
por: Lathia, Tejal, et al.
Publicado: (2021)

Is Insulin Resistance at Baseline a Predictor of Weight Loss After Bariatric Surgery?
por: Borges-Canha, Marta, et al.
Publicado: (2021)

RF24 | PSUN95 Defining Predictors of Weight Loss Response to Lorcaserin
por: Gugger, Aristea Sideri, et al.
Publicado: (2022)

SAT665 Effects Of Weight Cycling On Hepatic Protein Carbonylation And Lipid Peroxidation
por: Djalali-Gomez, Maya Aliyeh, et al.
Publicado: (2023)

SAT-120 Weight Regain after Bariatric Surgery Rectified by Dietary Intervention and Metformin
por: Torbay, Naji, et al.
Publicado: (2019)

MON-590 Presence of Diabetes Diminishes the Ultimate Weight Loss After Bariatric Surgery
por: Luo, Yingying, et al.
Publicado: (2020)

OR33-04 The Effect of Adiposity on the Fasting Serum Proteome in Normal Weight and Obese Men
por: Harshman, Stephanie Geris, et al.
Publicado: (2020)

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity
por: Huynh, Kim D, et al.
Publicado: (2021)

Preclinical Weight Loss Efficacy of AM833 in Combination With Semaglutide in Rodent Models of Obesity
por: John, Linu M, et al.
Publicado: (2021)

Breast Cancer Endocrine Therapy Exhausts Adipocyte Progenitors Promoting Weight Gain and Glucose Intolerance
por: Wellberg, Elizabeth A, et al.
Publicado: (2021)

Neurobiology of Avoidant/Restrictive Food Intake Disorder in Youth With Overweight/Obesity Versus Healthy Weight
por: Liya, Kerem, et al.
Publicado: (2021)

SAT656 Weight Reduction After 6 Months Of Setmelanotide Treatment In Patients With Hypothalamic Obesity
por: Roth, Christian L, et al.
Publicado: (2023)

OR01-1 Leveraging Immunometabolic Control to Prevent and Treat Obesity Related Asthma
por: Burak, M. Furkan, et al.
Publicado: (2019)

MON-109 Identifying Limiting Factors to Weight Loss and Prevention of Comorbidities in a Patient Population with Obesity
por: Johns, Allison, et al.
Publicado: (2019)

MON-LB102 Metformin-Induced Weight Loss in Patients With or Without Type 2 Diabetes/Prediabetes
por: Chukir, Tariq, et al.
Publicado: (2020)

Engagement in a Multi-Feature Digital Health Lifestyle Change Program as a Predictor of Weight Loss
por: Dzubur, Eldin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ua40rt350blkcstfs3e261gnhd